Worldwide, due to altered immunological reactivity, pregnant women represent a risk group during outbreaks of any infectious disease, especially in the presence of chronic extragenital pathology or a complicated course of pregnancy. To date, recommendations for the management of pregnant women with COVID-19 affecting nervous systems have a low level of evidence. The study of neurological and depressive disorders and their association with COVID-19 in pregnant women is a current problem in obstetrics and neurology. Due to the epidemic, the World Health Organization (WHO) "...has declared an international health emergency and the risks at the global level are estimated to be very high.